On this page 9 sections
PDRN has become the most requested active in our serum library, and the requests come almost entirely from dermatology and aesthetic clinics rather than retail brands. That tells you something about where it is genuinely useful — and it is worth understanding why before you put it on a label.
What PDRN actually is
PDRN stands for polydeoxyribonucleotide: short fragments of DNA, most commonly purified from salmon or trout milt. The salmon source is not marketing exotica. Fish-derived DNA has a high degree of homology with human DNA, and the extraction and purification process removes the protein content that would otherwise cause a reaction.
The proposed mechanism, in the literature around injectable PDRN, involves the adenosine A2A receptor and the salvage pathway that lets cells reuse nucleotides rather than synthesise them from scratch. In plain terms: the fragments are thought to act as signalling molecules and as raw material for cells that are busy rebuilding.
It has been used in medicine for a long time in that injectable form. The cosmetic, topical version is much newer, and that distinction is the single most important thing on this page.
Where the evidence is strong, and where it is thin
Be careful here, because a lot of marketing is not.
The substantial clinical literature on PDRN concerns injectable preparations — intradermal, intralesional, or as a registered medical product. That evidence does not automatically transfer to a serum applied to intact skin. DNA fragments are large, hydrophilic molecules, and the stratum corneum exists precisely to keep molecules like that out.
Published work on topical cosmetic PDRN is comparatively limited, and much of what circulates is manufacturer data rather than independent trials. Formulators address penetration with delivery strategies — low-molecular-weight fractions, humectant carriers, liposomal or encapsulated systems — and those approaches are reasonable, but "reasonable" is not the same as "demonstrated".
Why clinics use it in aftercare anyway
Given all of that, why is it the fastest-growing product in our clinic ranges? Three practical reasons.
It is genuinely soothing on compromised skin. A well-built PDRN serum is bland in the best sense: no acids, no retinoids, no fragrance, high humectant content. After microneedling, a laser pass or a peel, that is exactly what the skin wants, and patients report comfort immediately.
It fills a real gap in the aftercare tray. Clinics have plenty to sell for treating and plenty for protecting, and very little for the week afterwards. A serum that supports the skin barrier while it settles is a product patients understand and actually finish.
It gives a clinic line a credible hero. A dermatologist-branded range needs one product that is not available in every pharmacy. PDRN, formulated properly and packaged well, is that product in a way another niacinamide serum is not.
How we formulate it
Our PDRN Repair Serum runs PDRN at 0.5 to 1 per cent alongside multi-molecular hyaluronic acid and panthenol. A few notes on why it looks like that.
- Concentration is not the whole story. Above a certain point you are adding cost, not performance. Molecular weight distribution and the delivery system matter more than a bigger number on the front of the box.
- Keep the formula quiet. PDRN belongs in a low-irritation base. Pairing it with acids or high-strength actives defeats the purpose, particularly for post-procedure use.
- Preservation needs care. A nutrient-rich, high-water formula is a hospitable environment. The preservative system has to be robust and it has to be challenge-tested, not assumed.
- Stability is the real constraint. Nucleotide fragments are not indestructible. Formulation pH, temperature exposure and packaging all affect what is still there at month twelve, which is why stability data matters more for this active than for most.
Packaging is part of the formula
We supply PDRN serums in amber glass dropper bottles or airless pumps, at 20 or 30 ml, and the choice is not cosmetic.
A dropper is familiar and clinic-appropriate, but it reintroduces air on every use and invites contact between the pipette and the skin. An airless pump protects the formula better and doses more consistently, which matters for an ingredient whose stability you are trying to preserve, and it is the format we usually recommend for retail packs that will sit on a bathroom shelf for three months.
For clinic backbar use, where a bottle is opened often and finished quickly, the calculation is different and a dropper is fine. It is worth deciding which of the two your product is before you order packaging.
How to talk about it on a label
This is where clinics get into trouble, and where a manufacturer should be telling you no more often than yes.
In Pakistan, a claim can move a product between regulators. A cosmetic that only makes cosmetic claims sits under PSQCA and the relevant Pakistan Standard. A product that claims to treat a condition moves under DRAP, and the file, the testing and the timeline change with it. That is a regulatory consequence of a marketing sentence.
So the language we use, and recommend:
- Workable: helps skin look calmer and more even; supports the skin barrier; helps skin feel comfortable after in-clinic procedures; visibly plumper, more hydrated skin.
- Not workable on a cosmetic label: heals, repairs damage, regenerates tissue, treats scarring, accelerates wound healing, medical-grade.
The second list is not squeamishness. Those are therapeutic claims, and using them on a cosmetic invites both a regulatory problem and a credibility problem with the colleagues you most want to impress.
Backbar and retail are two different products
Clinics that do this well run the same formula in two sizes, and treat them as separate products commercially.
The backbar pack is larger, plainer and used by your staff during and immediately after a procedure. It does not need premium secondary packaging, and it should be priced as a consumable. Its job is to make the aftercare part of the treatment rather than an upsell.
The retail pack is the one the patient takes home, and it carries the full brand: printed carton, insert with a usage protocol, and a size that lasts roughly the interval until their next appointment. That last detail is worth thinking about — a 30 ml serum used twice daily runs out at about the right moment to prompt a return visit, which is why we recommend it over a larger bottle that outlives the treatment cycle.
Sample sachets are the third piece, and the cheapest marketing a clinic line has. A two-millilitre sachet handed over at the end of a consultation costs very little and does more than a discount code.
A note on exosomes, since the question always follows
PDRN and plant-derived exosomes get discussed together and they are not the same thing. Exosomes are vesicles carrying signalling molecules; the cosmetic-grade material used in Pakistan is plant-derived, typically from rose or centella stem cell culture. Human-derived exosomes are a different regulatory category entirely and are not something to put in a cosmetic serum on the strength of a supplier's enthusiasm.
If you are building an aftercare range, the two work well in sequence rather than in competition — but ask for a certificate of analysis showing particle concentration before you believe anything about an exosome raw material.
If you are considering it for your clinic
PDRN suits a clinic that does procedures and wants an aftercare product patients associate with them rather than with a pharmacy. It suits a range where it is the hero and the rest of the routine is sensible and affordable. It does not suit a brand that needs it to make claims it cannot support.
We manufacture PDRN serums as catalogue formulas you can put your brand on, or as custom formulations built around your own protocol, with stability data and independent test reports for your file. If you want to see and feel one before deciding, ask us for a sample.
